Moderate to Severe Psoriasis: 4th Edition (Hardback) book cover

Moderate to Severe Psoriasis

4th Edition

Edited by John Y. M. Koo, Jashin J. Wu, Alice B. Gottlieb, Ethan C. Levin, Argentina Leon

CRC Press

417 pages | 56 B/W Illus.

Purchasing Options:$ = USD
Hardback: 9781482215168
pub: 2014-03-18
SAVE ~$31.00
Currently out of stock
$155.00
$124.00
x
eBook (VitalSource) : 9780429172137
pub: 2014-03-18
from $77.50


FREE Standard Shipping!

Description

Written by experts in the dermatology field, this new fourth edition of Moderate-to-Severe Psoriasis discusses the current use of biologics and other pharmacologic and phototherapy treatments for moderate-to-severe psoriasis. Illustrated with high quality color figures, this standalone text emphasizes safe and effective treatments for the psoriasis patient that are perfect for the dermatologist in daily practice. New to this edition are chapters on day treatment programs, new agents, erythrodermic and pustular psoriasis, special populations, and pharmacogenetics.

Table of Contents

An Overview of Psoriasis, Alan Menter and Gerald Weinstein

Evaluating Psoriasis in Patients, John Koo, Jonathan Kowalski, Mark Lebwohl, Chris Kozma, Alan Menter, and Charles Ellis

Topical Agents in the Treatment of Moderate to Severe Psoriasis, Kristina Callis Duffin, and Gerald Krueger

The Art and Practice of UVB Phototherapy and Laser for the Treatment of Moderate-to-Severe PSO, Monica Huynh and John Koo

Systemic and Topical PUVA Therapy, Monica Huynh andWarwick Morison

Therapy of Moderate-To-Severe PSO with MTX, Gerald Weinstein, Arisa Ortiz and Anne Marie Tremaine

Systemic Retinoids, Daniel Butler, Tina Bhutani and John Koo

Cyclosporine in the treatment of severe PSO, Charles Ellis

Combination, Rotational, and Sequential Therapies, Jason Emer and Mark Lebwohl

Pediatric Psoriasis, Maya Debbaneh, Kelly Cordoro

Psoriatic Arthritis, Dafna Gladman

Etanercept for Treatment of Psoriasis, Daniel Butler and John Koo

Adalimumab in the Treatment of Psoriasis, Maya Debbaneh and John Koo

Infliximab in the treatment of PSO, Emily Becker and John Koo

New Agents: IL-17, JAK Kinase, Ethan Levin, Argentina Leon and John Koo

Ustekinumab, Ethan Levin and Andrew Blauvelt

Current and Potential Applications of Pharmacogenetics and Pharmacogenomics in the Treatment of PSO, Rishu Gupta, John Koo, Jashin Wu, and Wilson Liao

The Immunomodulatory/Immunosuppressive Classification System, John Koo, Shahrad Behnam, Shahdad Behnam, Dana Bae, Melanie Tuerk, Myriam Bernal, and Robert Dubois

Goeckerman and Ingram Day Treatment Program, Rishu Gupta and John Koo

Subject Categories

BISAC Subject Codes/Headings:
MED000000
MEDICAL / General
MED017000
MEDICAL / Dermatology
MED029000
MEDICAL / Family & General Practice